A Randomized, Blinded Study of Two Doses of Novastan® (Brand of Argatroban) Versus Heparin as Adjunctive Therapy to Recombinant Tissue Plasminogen Activator (Accelerated Administration) in Acute Myocardial Infarction: Rationale and Design of the Myocardial Infarction using Novastan® and T-PA (MINT) Study

By Jang I-K.   Giugliano R.P.   Massey T.J.   Schwarz Jr. R.P.  

Journal of Thrombosis and Thrombolysis, Vol. 5, Iss. 1, 1998-01 ,pp. : 49-52

Springer Publishing Company

Access to resources Recommend Favorite

Platelet aggregation by IgG anti-streptokinase and anisoylated plasminogen-streptokinase activator complex: heterogenous responses in platelet-rich plasma but not in washed platelets

By Abdelouahed M.   Elalamy I.   Samama M.M.   Hatmi M.  

Thrombosis Research, Vol. 86, Iss. 3, 1997-05 ,pp. : 255-262

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of a New Streptokinase Regimen with Enoxaparin in Acute Myocardial Infarction

By Tatu-Chitoiu Gabriel   Teodorescu Cristina   Dan Monica   Capraru Petre   Guran Manuela   Istratescu Oana   Tatu-Chitoiu Alexandrina   Bumbu Aurelia   Dorobantu Maria  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 3, 2003-06 ,pp. : 171-179

Springer Publishing Company

Access to resources Recommend Favorite

Relation of mortality of primary angioplasty during acute myocardial infarction to door to thrombolysis in myocardial infarction (TIMI) time

By Juliard J.M.   Feldman L.J.   Golmard J.L.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 54-55

Elsevier

Access to resources Recommend Favorite

Early Diagnosis and Exclusion of Acute Myocardial Infarction by Two Hours' Vector-ECG and Determination of Either Myoglobin or CK-mb

By Gustafsson Gunnar   Dellborga Mikael   Lindahl Bertil   Wallentin Lars  

Scandinavian Cardiovascular Journal, Vol. 34, Iss. 2, 2000-05 ,pp. : 172-177

Informa Healthcare

Access to resources Recommend Favorite